AKT1 and autoimmune polyendocrinopathy: Sun et al. (105) demonstrated that a 7-day preoperative injection of APS (1 mg/kg, once daily) significantly reduced serum levels of IL-6, IL-12, and VEGF in EC patients, potentially mediated via the p-AKT signaling pathway.